{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T19:56:28Z","timestamp":1794426988946,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004032","name":"Jilin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116551","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:29:21Z","timestamp":1713400161000},"page":"116551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"174","author":[{"given":"Tiane","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9739-1754","authenticated-orcid":false,"given":"Bingtong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","article-title":"The immunology of rheumatoid arthritis","volume":"22","author":"Weyand","year":"2021","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1515\/cclm-2013-0798","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide 2 antibody and anti-cyclic citrullinated peptide 3 antibody in rheumatoid arthritis","volume":"52","author":"Zhang","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"12","key":"10.1016\/j.biopha.2024.116551_bib3","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1007\/s10067-021-05814-4","article-title":"IgA rheumatoid factor is associated with bone mineral density preservation in rheumatoid arthritis","volume":"40","author":"Sghiri","year":"2021","journal-title":"Clin. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/03009742.2019.1609079","article-title":"Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR\/EULAR 2010 classification criteria for rheumatoid arthritis","volume":"49","author":"Tenstad","year":"2020","journal-title":"Scand. J. Rheuma"},{"issue":"7","key":"10.1016\/j.biopha.2024.116551_bib5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/annrheumdis-2017-212404","article-title":"Biomechanical properties of bone are impaired in patients with ACPA-positive rheumatoid arthritis and associated with the occurrence of fractures","volume":"77","author":"Stemmler","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00296-019-04492-5","article-title":"ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography","volume":"40","author":"Grosse","year":"2020","journal-title":"Rheuma Int"},{"issue":"12","key":"10.1016\/j.biopha.2024.116551_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/annrheumdis-2018-214967","article-title":"Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts","volume":"78","author":"Sun","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-023-03007-9","article-title":"Identification of anti-citrullinated osteopontin antibodies and increased inflammatory response by enhancement of osteopontin binding to fibroblast-like synoviocytes in rheumatoid arthritis","volume":"25","author":"Umemoto","year":"2023","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.biopha.2024.116551_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","article-title":"ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome","volume":"17","author":"Dong","year":"2020","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-018-1527-x","article-title":"Abatacept blocks anti-citrullinated protein antibody and rheumatoid factor mediated cytokine production in human macrophages in IDO-dependent manner","volume":"20","author":"Bozec","year":"2018","journal-title":"Arthritis Res Ther."},{"issue":"11","key":"10.1016\/j.biopha.2024.116551_bib11","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.1800534","article-title":"Citrullination controls dendritic cell transdifferentiation into Osteoclasts","volume":"202","author":"Krishnamurthy","year":"2019","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116551_bib12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib13","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10753-015-0188-z","article-title":"Anti-citrullinated protein antibodies induce macrophage subset disequilibrium in RA patients","volume":"38","author":"Zhu","year":"2015","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.chembiol.2018.03.002","article-title":"The rheumatoid arthritis-associated citrullinome","volume":"25","author":"Tilvawala","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"209","key":"10.1016\/j.biopha.2024.116551_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/scitranslmed.3006869","article-title":"Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis","volume":"5","author":"Romero","year":"2013","journal-title":"Sci. Transl. Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.116551_bib16","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1002\/art.22983","article-title":"Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation","volume":"56","author":"Foulquier","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.116551_bib17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3389\/fimmu.2017.01200","article-title":"Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils","volume":"8","author":"Zhou","year":"2017","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann. Rheum. Dis."},{"issue":"23","key":"10.1016\/j.biopha.2024.116551_bib19","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1007\/s00018-019-03237-8","article-title":"An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes","volume":"76","author":"Alghamdi","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2024.116551_bib20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2018.00034","article-title":"Perspective on protein arginine deiminase activity-bicarbonate is a ph-independent regulator of citrullination","volume":"9","author":"Zhou","year":"2018","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jb\/mvaa010","article-title":"Bicarbonate enhances the inflammatory response by activating JAK\/STAT signalling in LPS + IFN-\u03b3-stimulated macrophages","volume":"167","author":"Kawakami","year":"2020","journal-title":"J. Biochem"},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s12276-022-00756-6","article-title":"Dynamic synovial fibroblasts are modulated by NBCn1 as a potential target in rheumatoid arthritis","volume":"54","author":"Ji","year":"2022","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.biopha.2024.116551_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1046306","article-title":"Regional risk of tuberculosis and viral hepatitis with tumor necrosis factor-alpha inhibitor treatment: a systematic review","volume":"14","author":"Jahnich","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2024.116551_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109704","article-title":"Molecular mechanisms and clinical application of Iguratimod: a review","volume":"122","author":"Jiang","year":"2020","journal-title":"Biomed. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2024.116551_bib25","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s10067-019-04835-4","article-title":"Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients","volume":"39","author":"Li","year":"2020","journal-title":"Clin. Rheuma"},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00281-017-0634-0","article-title":"Cellular and molecular pathways of structural damage in rheumatoid arthritis","volume":"39","author":"Harre","year":"2017","journal-title":"Semin Immunopathol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.intimp.2012.03.003","article-title":"T-614 alters the production of matrix metalloproteinases (MMP-1 andMMP-3) and inhibits the migratory expansion of rheumatoid synovial fibroblasts, in vitro","volume":"13","author":"Du","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116551_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106510","article-title":"ERK is involved in the differentiation and function of dimethyl sulfoxide-induced HL-60 neutrophil-like cells, which mimic inflammatory neutrophils","volume":"84","author":"Wang","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116551_bib29","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.4049\/jimmunol.180.3.1895","article-title":"Histone deimination as a response to inflammatory stimuli in neutrophils","volume":"180","author":"Neeli","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"issue":"2","key":"10.1016\/j.biopha.2024.116551_bib31","first-page":"85","article-title":"Ionized calcium in body fluids","volume":"15","author":"Robertson","year":"1981","journal-title":"Crit. Rev. Clin. Lab Sci."},{"issue":"31","key":"10.1016\/j.biopha.2024.116551_bib32","doi-asserted-by":"crossref","first-page":"10570","DOI":"10.1021\/bi050292m","article-title":"Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis","volume":"44","author":"Kearney","year":"2005","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0143-4160(93)90008-T","article-title":"Sphingosine mobilizes intracellular calcium in human neutrophils","volume":"14","author":"Wong","year":"1993","journal-title":"Cell Calcium"},{"issue":"186","key":"10.1016\/j.biopha.2024.116551_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci. Transl. Med"},{"issue":"6","key":"10.1016\/j.biopha.2024.116551_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098794","article-title":"Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease","volume":"9","author":"Giles","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1159\/000358669","article-title":"Characterization of the Na\/HCO3(-) cotransport in human neutrophils","volume":"33","author":"Giambelluca","year":"2014","journal-title":"Cell Physiol. Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2024.116551_bib37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jlb.55.3.343","article-title":"Identification and characterization of human neutrophil carbonic anhydrase","volume":"55","author":"Campbell","year":"1994","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116551_bib38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/iub.1315","article-title":"Bicarbonate transport in health and disease","volume":"66","author":"Alka","year":"2014","journal-title":"IUBMB life"},{"issue":"11","key":"10.1016\/j.biopha.2024.116551_bib39","doi-asserted-by":"crossref","first-page":"R1447","DOI":"10.1152\/ajpregu.00150.2015","article-title":"The sodium-bicarbonate cotransporter NBCe2 (slc4a5) expressed in human renal proximal tubules shows increased apical expression under high-salt conditions","volume":"309","author":"Gildea","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189464","article-title":"Sodium bicarbonate cotransporter NBCe2 gene variants increase sodium and bicarbonate transport in human renal proximal tubule cells","volume":"13","author":"Gildea","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2024.116551_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.911810","article-title":"Effectiveness and safety of iguratimod monotherapy or combined with methotrexate in treating rheumatoid arthritis: a systematic review and meta-analysis","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s13018-021-02603-2","article-title":"Effectiveness of iguratimod as monotherapy or combined therapy in patients with rheumatoid arthritis: a systematic review and meta-analysis of RCTs","volume":"16","author":"Hu","year":"2021","journal-title":"J. Orthop. Surg. Res"},{"issue":"7","key":"10.1016\/j.biopha.2024.116551_bib43","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/art.24643","article-title":"Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate","volume":"61","author":"Lu","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/14397595.2020.1740390","article-title":"Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors","volume":"31","author":"Hattori","year":"2021","journal-title":"Mod. Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2024.116551_bib45","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/mr\/roac060","article-title":"Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: adjusted with propensity score matching","volume":"33","author":"Nozaki","year":"2023","journal-title":"Mod. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/14397595.2020.1740390","article-title":"Efficacy of add-on iguratimod in patients with rheumatoid arthritis who inadequately respond to either tocilizumab or tumor necrosis factor alpha inhibitors","volume":"31","author":"Hattori","year":"2021","journal-title":"Mod. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116551_bib47","doi-asserted-by":"crossref","first-page":"R20","DOI":"10.1186\/ar3702","article-title":"Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis","volume":"14","author":"Makrygiannakis","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.biopha.2024.116551_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8549329","article-title":"Neutrophil function in an inflammatory milieu of rheumatoid arthritis","volume":"2018","author":"Chen","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"7","key":"10.1016\/j.biopha.2024.116551_bib49","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1529-0131(200007)43:7<1488::AID-ANR11>3.0.CO;2-G","article-title":"Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients","volume":"43","author":"Kraan","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2024.116551_bib50","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1203\/00006450-199910000-00008","article-title":"Mechanism for dexamethasone inhibition of neutrophil migration upon exposure to lipopolysaccharide in vitro: role of neutrophil interleukin-8 release","volume":"46","author":"Zentay","year":"1999","journal-title":"Pedia Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:11:00Z","timestamp":1782342660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"alternative-id":["S0753332224004359"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116551","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116551"}}